U.S. Electronic Equipment and Components Stock News

Earlier this year, Karooooo’s subsidiary Cartrack announced it had surpassed two million active subscribers in South Africa, marking a key scale milestone for its mobility solutions platform. This subscriber threshold reinforces Cartrack’s entrenched position in its core market and highlights how product innovation and customer focus support its South African footprint. Next, we’ll examine how crossing two million South African subscribers could influence Karooooo’s investment narrative...

Kansas City Life Insurance (KCLI) has wrapped up FY 2025 with fourth quarter revenue of US$120.4 million, basic EPS of US$0.23 and net income of US$2.3 million, alongside trailing 12 month revenue of US$485.5 million and a net loss of US$20.8 million, which translates to basic EPS of a US$2.14 loss. Over recent quarters the company has seen revenue move between US$118.98 million and US$125.15 million, while quarterly EPS has ranged from a US$2.90 loss to a US$0.33 profit. This sets up a story...

Inland Real Estate Income Trust (INRE) has posted its FY 2025 numbers with Q4 total revenue of US$38.7 million and a basic EPS loss of US$0.12, alongside funds from operations of US$36.3 million in the red. This gives investors a mixed read on operating performance and cash generation. Over the past year, total revenue has held in a tight band around US$150 million on a trailing twelve month basis while basic EPS for the same period came in at a loss of US$0.31, underscoring a sustained loss...

Mistras Group (MG) just closed out FY 2025 with fourth quarter revenue of US$181.5 million and basic EPS of US$0.12, alongside trailing twelve month revenue of US$724.0 million and EPS of US$0.54 that were shaped by a reported net profit margin of 2.3%. Over recent periods, the company has seen quarterly revenue move from US$172.7 million in FY 2024 Q4 to US$195.5 million in FY 2025 Q3 before landing at US$181.5 million in FY 2025 Q4. Quarterly EPS ranged from a loss of US$0.10 in FY 2025 Q1...

TechTarget (TTGT) has just posted its FY 2025 numbers with Q4 revenue of US$140.7 million and a basic EPS loss of US$0.13, capping a trailing 12 month period that featured revenue of US$486.8 million and a basic EPS loss of US$14.06. Over recent quarters, the company has seen revenue move from US$99.9 million in Q4 FY 2024 to US$103.9 million in Q1 FY 2025, US$119.9 million in Q2, US$122.3 million in Q3 and US$140.7 million in Q4. Quarterly basic EPS losses shifted from US$0.90 to US$7.32,...

Build A Bear Workshop (BBW) has just reported new figures for FY 2026, with third quarter revenue of US$122.7 million and basic EPS of US$0.62. Trailing twelve month figures show revenue of US$525.8 million and EPS of US$4.38 backed by net income of US$57.5 million. Over recent quarters the company has seen revenue move from US$119.4 million in Q3 2025 to US$150.4 million in Q4 2025 and then to US$128.4 million and US$124.2 million in Q1 and Q2 2026. Basic EPS was US$0.64, US$1.63, US$1.17...

Sealed Air (NYSE:SEE) has announced its intention to redeem multiple senior notes, subject to the closing of a pending transaction. The planned redemptions would retire certain outstanding debt instruments once the transaction is completed. The company has outlined the expected redemption terms ahead of closing to give bondholders and shareholders clarity on next steps. For investors watching Sealed Air, the focus now is on how this conditional redemption plan fits with the company’s...

If you are looking at Worthington Enterprises and wondering whether the current share price reflects its true value, this article will walk you through what the numbers are actually saying. The stock last closed at US$46.99, after a 7 day return of a 9.9% decline, a 30 day return of an 18.8% decline, a year to date return of a 9.6% decline, but a 1 year return of 18.8% and a 3 year return of 47.2% that sits ahead of its 5 year return of 16.3%. Recent coverage around Worthington Enterprises...

If you are wondering whether Amicus Therapeutics at around US$14.37 is attractively priced or already reflecting a lot of optimism, you are in the right place to focus on what the numbers are actually saying about value. The stock's return profile, with 0.3% over the last 7 days, 0.5% over 30 days, 0.7% year to date and 61.6% over 1 year, suggests the market has been reassessing the company over different time frames. Recent news around Amicus Therapeutics has continued to center on its role...

Zoetis (NYSE:ZTS) is expanding its support for veterinary education by offering free Human Animal Bond Certification to veterinary technician students across the US. The program extends an existing scholarship initiative and now targets a broader segment of the veterinary care team. This move focuses on the relationship between people and animals, a core element of modern companion animal and livestock care. For investors watching NYSE:ZTS, this update fits within Zoetis’s role as a global...

Tenaya Therapeutics (TNYA) is back in focus after reporting a full year 2025 net loss of US$90.6 million, alongside fresh preclinical data and a new collaboration in cardiovascular and muscular disease programs. See our latest analysis for Tenaya Therapeutics. The recent MDA 2026 data for TN-301 and the new Alnylam collaboration appear to have sharpened market focus, with a 7 day share price return of 47.70% standing in contrast to a 36.86% decline over 90 days and a 3 year total shareholder...

Centessa Pharmaceuticals recently reported past Phase II progress for its orexin agonist ORX750 in narcolepsy type 1, narcolepsy type 2 and idiopathic hypersomnia, highlighting clinically meaningful effects alongside a favorable safety and tolerability profile. The company also outlined plans for registrational studies in rare hypersomnias, expanded its open-label extension to four weeks, and began preparing for regulatory engagement and commercial build-out, underscoring how central ORX750...

Netskope, Inc. has reported its fourth-quarter 2026 results, with sales of US$196.33 million and a net loss of US$56.77 million, and unveiled guidance for fiscal 2027 alongside the launch of its Netskope One AI Security suite. The introduction of Netskope One AI Security, which combines agentic AI protection, guardrails, gateways, and red teaming in a unified platform, positions the company directly in the emerging market for securing generative and enterprise AI use. We’ll now examine how...

Campbell's (CPB) has just reported its latest results with Q2 2026 revenue of US$2.68 billion and basic EPS of US$0.65, setting the tone for how the rest of the year may shape up. Looking back over recent quarters, revenue has moved between US$2.29 billion in Q4 2024 and US$2.77 billion in Q1 2025, while basic EPS has ranged from a small loss of US$0.01 in Q4 2024 to US$0.73 in Q1 2025. This gives investors a clear view of how sales and earnings have tracked into this quarter. With net income...

Conference spotlight and why AIRO is on more investor radars AIRO Group Holdings (AIRO) is set to present at the 2026 Cantor Global Technology & Industrial Growth Conference on March 11 in New York, giving investors a closer look at its aerospace and defense business. With Co Founder and Executive Chairman Chirinjeev Baboo Kathuria, Chief Executive Officer Joe Burns and Chief Financial Officer Mariya Pylypiv on stage, the session could offer more detail on AIRO’s drone, avionics, training and...

Utz Brands (NYSE:UTZ) presented new protein-enriched snacks and globally inspired flavors at Natural Products Expo West. The lineup includes Boulder Canyon Agave Sriracha kettle chips and a high protein snack range with gluten free, non GMO, and kosher options. The launch targets growing interest in snacks that combine higher protein content with bolder, globally influenced taste profiles. For investors watching NYSE:UTZ, the new products come at a time when the share price is around $7.52,...

C.H. Robinson Worldwide (NasdaqGS:CHRW) has publicly detailed the scale of its proprietary logistics dataset, which now feeds over 100 trillion real world data points into its Lean AI system. The expanded AI platform coordinates hundreds of AI agents that support millions of shipping decisions across global freight and logistics operations. The company reports measurable benefits for customers, including faster time to market and more consistent pickup performance. C.H. Robinson is putting...

Wondering whether Capricor Therapeutics at around US$33.57 is still offering value or has already priced in the story? This article will walk you through what the numbers are actually saying about the stock. The share price has been volatile, with returns of 31.6% over the past week, 33.3% over the past month, 18.6% year to date, and 156.8% over the last year, alongside a very large 3 year gain and a more than 5x gain over 5 years. Recent interest in Capricor Therapeutics has been shaped by...

Mosaic (NYSE:MOS) has entered a joint agreement with Rainbow Rare Earths to advance the Uberaba rare earths project in Brazil. The partners plan to process phosphogypsum, a fertilizer byproduct, to produce rare earths such as neodymium and praseodymium. The initiative expands Mosaic’s business focus beyond fertilizers into materials used in clean energy and high tech applications. Mosaic, trading at $29.15, is better known for its fertilizers, so this rare earths move gives investors a...

Valvoline (NYSE:VVV) has launched the Happy to Help Fund in partnership with Blue Grass Community Foundation to back mental and physical well-being projects for children and youth in Lexington. The company has named Jordan M. Denny as Chief Accounting Officer and Controller, marking a key update to its executive leadership team. For you as an investor, this pairs a fresh community initiative with a leadership change at a company best known for vehicle lubricants, services, and related...

Immunic (IMUX) is back on investors’ radar after proposing a reverse stock split ahead of an April 14 special shareholder meeting, while management prepares to speak at the Leerink Global Healthcare Conference on March 11. See our latest analysis for Immunic. Those recent corporate updates have come alongside sharp share price moves, with a 1 day share price return of 12.4% and a 30 day share price return of 103.08% contributing to a year to date share price return of 148.71%. However, the 5...

Vanda Pharmaceuticals recently received a decision from the U.S. FDA granting a rare formal evidentiary public hearing to review the agency’s proposed refusal to approve a supplemental new drug application for HETLIOZ (tasimelteon) as a treatment for jet lag disorder. This hearing, which follows Vanda’s earlier legal win requiring the FDA to more fully address its clinical evidence, highlights unusually high regulatory and scientific scrutiny around expanding HETLIOZ into a large, currently...

If you are wondering whether Papa John's International is priced attractively right now, it helps to step back and look at what the recent share performance and fundamentals are really telling you. The stock closed at US$38.86 recently, with a sharp 26.1% return over the last 7 days and 11.5% over the last 30 days, while year to date the return sits at a 3.6% decline and the 1 year return is a 7.5% decline, compared to a 46.0% decline over 3 years and a 49.9% decline over 5 years. Recent...

New 52-week high puts recent gains in focus Coda Octopus Group (CODA) has hit a new 52-week high, coinciding with higher operating profit and a firm market position, drawing more investor attention to how the stock’s recent strength lines up with its fundamentals. See our latest analysis for Coda Octopus Group. The share price has slipped back 12.8% over the last day to US$14.62, but that comes after a strong run, with a 90-day share price return of 62.4% and a 1-year total shareholder return...